Overview

A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

The study will test the hypothesis that, in patients with knee pain due to osteoarthritis (OA) who are taking nonsteroidal anti-inflammatory drugs (NSAIDs) but still have significant knee pain, duloxetine 60 to 120 milligrams (mg) daily for 10 weeks will provide additional reduction in pain.

Phase:

Phase 3

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Duloxetine Hydrochloride